Cytotoxic Effect of Voriconazole on Human Corneal Epithelial Cells

被引:8
作者
Sobolewska, Bianka [1 ]
Guerel, Guelhan [1 ]
Hofmann, Johanna [1 ]
Tarek, Bayyoud [1 ]
Bartz-Schmidt, Karl-Ulrich [1 ]
Yoeruek, Efdal [1 ]
机构
[1] Univ Tubingen, Ctr Ophthalmol, DE-72076 Tubingen, Germany
关键词
Fungal keratitis; Acanthamoeba keratitis; Voriconazole Sulfobutylether-beta-cyclodextrin; Toxicity; Cell culture; Human corneal epithelial cells; IN-VITRO ACTIVITIES; ANTIFUNGAL AGENTS; AQUEOUS-HUMOR; ACANTHAMOEBA; SUSCEPTIBILITY; KERATITIS; NATAMYCIN; 1-PERCENT; YEASTS;
D O I
10.1159/000371712
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: To assess the cytotoxic properties of voriconazole and sulfobutylether-P-cyclodextrin (SBECD) on cultured primary human corneal epithelial cells. Methods: Human corneal epithelial cells were cultured and exposed to various concentrations of SBECD (0.016-32 mg/ml) and voriconazole (0.001-2 mg/ml). Cellular cytotoxicity of SBECD and voriconazole on human corneal epithelial cells was evaluated using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide test and the LIVE/DEAD Viability/Cytotoxicity Assay with fluorescence microscopy analysis. Cell damage was assessed with phase-contrast microscopy after 24 h of exposure to SBECD and voriconazole. Results:The cytotoxicity tests and the morphological characteristic demonstrated the dose-dependent toxic effect of SBECD and voriconazole on human corneal epithelial cells. No corneal epithelial cytotoxicity was observed below the concentration of 0.08 and 0.025 mg/ml after 24-hour exposure to SBECD and voriconazole, respectively. Conclusions: The results of the study reveal the dose-dependent cytotoxic effect of SBECD and voriconazole on cultured human corneal epithelial cells. Therefore, voriconazole eye drops should be used cautiously in the treatment of fungal corneal ulcers. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:41 / 47
页数:7
相关论文
共 25 条
  • [1] Al-Badriyeh D, 2010, CLIN OPHTHALMOL, V4, P391
  • [2] Treatment With Voriconazole in 3 Eyes With Resistant Acanthamoeba Keratitis
    Bang, Stacy
    Edell, Erica
    Eghrari, Allen O.
    Gottsch, John D.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (01) : 66 - 69
  • [3] Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses
    Clode, AB
    Davis, JL
    Salmon, J
    Michau, TM
    Gilger, BC
    [J]. AMERICAN JOURNAL OF VETERINARY RESEARCH, 2006, 67 (02) : 296 - 301
  • [4] Gao Hua, 2003, Trans Am Ophthalmol Soc, V101, P183
  • [5] Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance
    Ghannoum, MA
    Rice, LB
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (04) : 501 - +
  • [6] Cytotoxicity of Voriconazole on Cultured Human Corneal Endothelial Cells
    Han, Sang Beom
    Shin, Young Joo
    Hyon, Joon Young
    Wee, Won Ryang
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (10) : 4519 - 4523
  • [7] Hariprasad SM, 2008, BR J OPHTHALMOL, V5, P275
  • [8] Voriconazole: A new triazole antifungal agent
    Johnson, LB
    Kauffman, CA
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) : 630 - 637
  • [9] Intracameral voriconazole: In vitro safety for human ocular cells
    Kernt, M.
    Kamplik, A.
    [J]. TOXICOLOGY, 2009, 258 (2-3) : 84 - 93
  • [10] Activities of antifungal agents against yeasts and filamentous fungi:: Assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing
    Lass-Floerl, Cornelia
    Mayr, Astrid
    Perkhofer, Susanne
    Hinterberger, Guido
    Hausdorfer, Johann
    Speth, Cornelia
    Fille, Manfred
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (10) : 3637 - 3641